Guardant Health erhlt EU-IVDR-Zertifizierung fr Flssigbiopsie Guardant360 CDx zur Erstellung von Tumormutationsprofilen fr alle soliden Krebsarten und therapiebegleitende Diagnostika-Indikationen
GH Stock | USD 35.66 0.13 0.37% |
Under 50% of Guardant Health's traders are presently thinking to get in. The analysis of overall sentiment of trading Guardant Health stock suggests that some investors are interested at this time. Guardant Health's investing sentiment shows overall attitude of investors towards Guardant Health.
Guardant |
Guardant Health, Inc. , ein fhrendes Unternehmen im Bereich der Przisionsonkologie, gab heute die Zertifizierung seines Bluttests Guarda
Read at businesswire.com
Guardant Health Fundamental Analysis
We analyze Guardant Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Guardant Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Guardant Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Owned By Institutions
Shares Owned By Institutions Comparative Analysis
Guardant Health is currently under evaluation in shares owned by institutions category among its peers. Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
Guardant Health Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Guardant Health stock to make a market-neutral strategy. Peer analysis of Guardant Health could also be used in its relative valuation, which is a method of valuing Guardant Health by comparing valuation metrics with similar companies.
Peers
Guardant Health Related Equities
ILMN | Illumina | 0.68 | ||||
CDNA | Caredx | 0.46 | ||||
DHR | Danaher | 0.45 | ||||
NTRA | Natera | 0.40 | ||||
TMO | Thermo Fisher | 0.28 | ||||
CSTL | Castle Biosciences | 0.51 | ||||
PSNL | Personalis | 1.06 | ||||
A | Agilent Technologies | 1.44 | ||||
CRL | Charles River | 1.78 | ||||
TWST | Twist Bioscience | 5.24 | ||||
MYGN | Myriad Genetics | 5.41 |
Complementary Tools for Guardant Stock analysis
When running Guardant Health's price analysis, check to measure Guardant Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guardant Health is operating at the current time. Most of Guardant Health's value examination focuses on studying past and present price action to predict the probability of Guardant Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guardant Health's price. Additionally, you may evaluate how the addition of Guardant Health to your portfolios can decrease your overall portfolio volatility.
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |